[Available transvenous occluder designs and implantation techniques]

Area of Science:

• Cardiovascular Devices
• Medical Technology
• Interventional Cardiology

Background:

• Left atrial appendage (LAA) occlusion is a crucial strategy for stroke prevention in patients with atrial fibrillation.
• Various LAA occlusion devices are available or nearing market release, each with distinct design principles.
• Understanding device structure and implantation is vital for effective clinical application.

Purpose of the Study:

• To provide a comprehensive overview of current and near-future left atrial appendage (LAA) occlusion devices.
• To analyze the structural differences and implantation techniques of prominent LAA occlusion systems.
• To compare the occlusion concepts employed by different LAA closure devices.

Main Methods:

• Review and analysis of available literature and device information.
• Comparative assessment of structural designs and functional principles of LAA occlusion devices.
• Categorization of devices based on their occlusion mechanisms and implantation sequences.

Main Results:

• Several LAA occlusion devices, including Watchman™ and Occlutech®, utilize a single-component design implanted within the LAA orifice.
• Devices such as Amulet™ and Lambre™ feature a two-component system with distal anchoring and a left atrial disc for orifice coverage.
• The WaveCrest® device employs an initial orifice covering followed by a rolling anchoring system for fixation.

Conclusions:

• LAA occlusion devices exhibit diverse structural and functional designs, impacting their implantation and occlusion efficacy.
• The choice of device depends on specific anatomical considerations and the desired occlusion strategy.
• Continued innovation in LAA occlusion technology aims to improve safety and effectiveness in stroke risk reduction.